Are you Dr. Byrd?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 58 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4525 3rd Ave SE Ste 200
PMG SW WA PRCS Lacey Clinic
Lacey, WA 98503Phone+1 360-754-3934Fax+1 360-943-8023
Summary
- Dr. Daniel Byrd, MD is an oncologist in Lacey, Washington. He is currently licensed to practice medicine in Washington and Oregon. He is affiliated with Providence St. Peter Hospital, Multicare Capital Medical Center, and Mason Health.
Education & Training
- Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2005 - 2009
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2003 - 2005
- University of Texas Southwestern Medical SchoolClass of 2003
Certifications & Licensure
- OR State Medical License 2006 - Present
- WA State Medical License 2010 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 18 citationsChronic myelogenous leukemia and benzene exposure: a systematic review and meta-analysis of the case-control literature.Steven H. Lamm, Arnold Engel, Kiran P. Joshi, Daniel M. Byrd, Rusan Chen
Chemico-Biological Interactions. 2009-12-10 - 27 citationsDirect Effects of HIV-1 Tat on Excitability and Survival of Primary Dorsal Root Ganglion Neurons: Possible Contribution to HIV-1-Associated PainXianxun Chi, Tohti Amet, Daniel Byrd, Kuei Hua Chang, Kavita Shah
Plos One. 2011-09-02 - 34 citationsA High-Affinity Inhibitor of Human CD59 Enhances Complement-Mediated Virolysis of HIV-1: Implications for Treatment of HIV-1/AIDSWeiguo Hu, Qigui Yu, Ningjie Hu, Daniel Byrd, Tohti Amet
Journal of Immunology. 2010-01-01